Molecular diagnosis of Williams Buren syndrome in a cohort of Sri Lankan patients

dc.contributor.authorRanaweera, D.M.
dc.contributor.authorde Silva, D.
dc.contributor.authorSamarasinghe, D.
dc.contributor.authorPerera, S.
dc.contributor.authorRajapaksha, N.
dc.contributor.authorChandrasekharan, N.V.
dc.date.accessioned2016-03-28T05:46:55Z
dc.date.available2016-03-28T05:46:55Z
dc.date.issued2012
dc.descriptionOral Presentation Abstract (OP 34), 125th Anniversary Scientific Medical Congress, Sri Lanka Medical Association, June 2012 Colombo, Sri Lankaen_US
dc.description.abstractINTRODUCTION: Williams Bueren Syndrome (WBS) is a common genetic cause of congenital heart defects associated with developmental delay, hypercalcaemia and characteristic facial dysmorphism. It is caused by a 1.5 to 1.8 Mb deletion of chromosome 7qll.23 involving the loss of around 23 genes including the elastin (ELN) gene. This study reports the development of a semi quantitative PCR method to diagnose WBS. AIMS: To establish a molecular diagnostic test for WBS and determine the frequency of ELN deletions among clinically suspected cases. METHODS: Sixteen suspected WBS cases identified by two paediatric cardiologists were recruited following ethical clearance and informed consent. DNA was extracted and dosage analysis was carried out using semi-quantitative PCR. In a multiplex PCR reaction normal (N), positive control (with a confirmed deletion) and patients' (PJ DNA was amplified using 2 primer pairs which amplified regions within the ELN gene and the CFTR gene on chromosome 7 but outside the deleted region. Following agarose gel electrophoresis, the amplified products were quantified. A ratio of P:N of 0.5 indicated the presence of a deletion while a ratio of 1 indicated the absence of a deletion. RESULTS: Among sixteen suspected cases, 12 (75%) had an ELN gene deletion while 4 cases did not. CONCLUSIONS: This semi-quantitative PCR method was able to distinguish ELN deleted cases from the non deleted ones. The preliminary data supports this as a useful diagnostic test for WBS but validation is required before its clinical use.en_US
dc.identifier.citationSri Lanka Medical Association, 125th International Medical Congress. 2012;57 Suppliment1: 30en_US
dc.identifier.issn0009-0895
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/12368
dc.language.isoen_USen_US
dc.publisherSri Lanka Medical Associationen_US
dc.subjectMolecular diagnosisen_US
dc.titleMolecular diagnosis of Williams Buren syndrome in a cohort of Sri Lankan patientsen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: